wada website has much info, including meeting minutes in full. Well done John Fahey for creating transparency. Much cycling discussion there, and indeed some discussion that can be linked to specific doping cases.
Also an interesting mention on significant funding to SportAccord, an organization run by Verbruggen/McQuaid and others.
http://www.wada-ama.org/en/About-WADA/Governance/Executive-Committee/
Below are from the WADA Director General’s report (Mr David Howman) at 2 specific meetings
from 19 Nov 2011 meeting:
“ WADA had had informal discussions with them (ANADO) along the lines that WADA might be prepared to consider funding in the same way as it had funded SportAccord (it provided 160,000 Swiss francs annually to SportAccord under certain conditions that had been followed very properly by SportAccord, to the benefit of all concerned).” …“WADA provided the money to SportAccord on the basis that it was not to be spent for doping tests (it was to be spent only on overheads in relation to the operation of the unit, which included the salaries of those employed by SportAccord) and that WADA had a position as an advisory member of its committee and received audited reports from the body in relation to its activities.”
...
Discussion of the outcomes of the WADA research programme on pg 46 of the meeting minutes Pat McQuaid asked
“Dr Rabin had mentioned autologous blood transfusion, and he saw that it had been number one on the list of priorities for 2011, and WADA was now heading into 2012. Where was WADA with that and how did Dr Rabin see it in the short term in terms of WADA having an actual validated test for it? The second question, which was somewhat related to that, was about plasticizers: where was WADA with a test for plasticizers?”
from 1 Dec 2009:
Another issue that WADA faced in terms of the laboratories was that there were antidoping organisations sending samples to the laboratories with the request to have them analysed under a selective, and quite a reduced, menu. WADA did not have access to these contracts, but it should have, and again he asked the Executive Committee to consider a direction to the Laboratory Committee to examine the issue to see whether there were ways and means of WADA having access to the contracts that the laboratories had as part of the accreditation or reaccreditation process.
Another area on the subject of doping control and collection of samples was that it had been brought to his attention that some samples collected in competition were designated on the doping control forms as out-of-competition tests, which obviously led to the samples being collected for the out-of-competition testing menu, perhaps avoiding substances. That would be a breach of the standard and could lead to the board considering this a matter of non-compliance. There were no details as yet, and the only way in which it would be possible to get details was through access to more information from the laboratories.
He had included bribery and corruption again in his report just for this meeting, but he would not repeat it the following day at the Foundation Board meeting. WADA had been working with the Austrian authorities about the allegations raised about individuals at that laboratory being open to bribes and helping athletes’ agents. The inquiry had not finished, but WADA had been told that there was nobody directly engaged in the laboratory activities who might be involved. The bigger question was whether there was somebody on the periphery, and that inquiry was still ongoing and he could not provide any update until it was completed, but it showed that the very core of what was being done in the fight against doping in sport could be undone in a fashion that bordered on bribery and corruption.